Research output

Research output per year 1999 2007 2008 2009 2011 2012 2013 2018 2019 2023

• 103 Article
• 12 Letter
• 6 Review article
• 2 Chapter
• 3 More
  • 2 Editorial
  • 1 Comment/debate

Research output per year

Research output per year

Search results

• 2023

  Coexistence of multiple sclerosis and spinocerebellar ataxia type-8

  Neyal, N., Keegan, B. M., Kantarci, O. H. & Zeydan, B., Aug 2023, In: Multiple Sclerosis Journal. 29, 9, p. 1195-1198 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Spinocerebellar ataxia 8 100%
  • Multiple Sclerosis 46%
  • Spinocerebellar Degenerations 21%
  • Spinocerebellar Ataxias 10%
  • Cerebellar Diseases 9%

• Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy

  Hasan, S., Zorio, O., Keegan, B. M., Weinshenker, B. G., Flanagan, E. P., Tobin, W. O., Kantarci, O. H., Toledano, M., Pittock, S. J., Lopez-Chiriboga, S., Zekeridou, A. & Valencia-Sanchez, C., Oct 2023, In: Journal of Neurology. 270, 10, p. 4707-4712 6 p.

  Research output: Contribution to journal › Letter › peer-review

• Progressive motor impairment from “critical” demyelinating lesions of the cervicomedullary junction

  Jackson-Tarlton, C. S., Flanagan, E. P., Messina, S. A., Barakat, B., Ahmad, R., Kantarci, O. H., Weinshenker, B. G. & Keegan, B. M., Jan 2023, In: Multiple Sclerosis Journal. 29, 1, p. 74-80 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Demyelinating Diseases 100%
  • Spinal Cord 46%
  • Quadriplegia 23%
  • Cervical Cord 22%
  • Paresis 20%

• Spinal cord and brain corticospinal tract lesions are associated with motor progression in tumefactive multiple sclerosis

  Jackson-Tarlton, C. S., Keegan, B. M., Fereidan-Esfahani, M., Barakat, B. O., Decker, P. A., Lucchinetti, C. F., Eckel-Passow, J. & Tobin, W. O., May 2023, In: Multiple Sclerosis and Related Disorders. 73, 104614.

  Research output: Contribution to journal › Article › peer-review

  • Pyramidal Tracts 100%
  • Multiple Sclerosis 71%
  • Spinal Cord 66%
  • Brain 39%
  • Demyelinating Diseases 28%
• 2022

  Cerebrospinal fluid evaluation in patients with progressive motor impairment due to critical central nervous system demyelinating lesions

  Barakat, B., Messina, S., Nayak, S., Kassa, R., Sechi, E., Flanagan, E. P., Kantarci, O., Weinshenker, B. G. & Keegan, B. M., Jan 2022, In: Multiple Sclerosis Journal - Experimental, Translational and Clinical. 8, 1

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Oligoclonal Bands 100%
  • Cerebrospinal Fluid 61%
  • Immunoglobulin G 53%
  • Central Nervous System 52%
  • Demyelinating Diseases 24%

• Diagnosis of coexistent neurodegenerative dementias in multiple sclerosis

  Londono, D. P., Arumaithurai, K., Constantopoulos, E., Basso, M. R., Ross Reichard, R., Flanagan, E. P. & Mark Keegan, B., 2022, In: Brain Communications. 4, 4, fcac167.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Dementia 94%
  • Biomarkers 65%
  • Autopsy 63%
  • Cognitive Dysfunction 61%
• 2021

  Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders

  Sechi, E., Krecke, K. N., Messina, S. A., Buciuc, M., Pittock, S. J., Chen, J. J., Weinshenker, B. G., Lopez-Chiriboga, A. S., Lucchinetti, C. F., Zalewski, N. L., Tillema, J. M., Kunchok, A., Monaco, S., Morris, P. P., Fryer, J. P., Nguyen, A., Greenwood, T., Syc-Mazurek, S. B., Keegan, B. M. & Flanagan, E. P., Sep 14 2021, In: Neurology. 97, 11, p. E1097-E1109

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Aquaporin 4 100%
  • Neuromyelitis Optica 99%
  • Central Nervous System Diseases 88%
  • Demyelinating Diseases 85%
  • Multiple Sclerosis 65%

• Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: A population-based case-control study

  Sechi, E., Messina, S., Keegan, B. M., Buciuc, M., Pittock, S. J., Kantarci, O. H., Weinshenker, B. G. & Flanagan, E. P., Apr 2021, In: Multiple Sclerosis Journal. 27, 5, p. 667-673 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Spinal Cord 92%
  • Case-Control Studies 91%
  • Population 44%
  • Chronic Progressive Multiple Sclerosis 26%

• Inflammatory activity following motor progression due to critical CNS demyelinating lesions

  Nayak, S., Sechi, E., Flanagan, E. P., Messina, S., Kassa, R., Kantarci, O., Weinshenker, B. G. & Keegan, B. M., Jun 2021, In: Multiple Sclerosis Journal. 27, 7, p. 1037-1045 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Sclerosis 100%
  • Motor Activity 99%
  • Central Nervous System 68%
  • Recurrence 44%
  • Paresis 32%

• Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesions

  Kassa, R. M., Sechi, E., Flanagan, E. P., Kaufmann, T. J., Kantarci, O. H., Weinshenker, B. G., Mandrekar, J., Schmalstieg, W. F., Paz Soldan, M. M. & Keegan, B. M., May 2021, In: Multiple Sclerosis Journal. 27, 6, p. 895-902 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Paresis 100%
  • Central Nervous System 86%
  • Sclerosis 75%
  • Magnetic Resonance Imaging 62%
  • Brain 34%

• Retinal vasculopathy with cerebral leukoencephalopathy due to TREX-1 mutation: An important mimicker of CNS inflammatory disease

  Weerasekare, J., Kassa, R. & Keegan, B. M., Jan 2021, In: Multiple Sclerosis and Related Disorders. 47, 102639.

  Research output: Contribution to journal › Letter › peer-review
• 2020

  Association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events

  Kunchok, A., Aksamit, A. J., Davis, J. M., Kantarci, O. H., Keegan, B. M., Pittock, S. J., Weinshenker, B. G. & McKeon, A., Aug 2020, In: JAMA neurology. 77, 8, p. 937-946 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Central Nervous System 61%
  • Autoimmune Diseases 35%
  • Rheumatoid Arthritis 27%
  • Odds Ratio 15%
  • Medical Records 13%
  17 Scopus citations

• Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event

  Lebrun-Frenay, C., Kantarci, O., Siva, A., Sormani, M. P., Pelletier, D., Okuda, D. T., Azevedo, C., Amato, M. P., Bensa, C., Berger, E., Brochet, B., Ciron, J., Cohen, M., Inglese, M., Keegan, B. M., Labauge, P., Laplaud, D. A., Le Page, E., Louapre, C., Makhani, N., & 13 othersMathey, G., Mondot, L., Montalban, X., Pelletier, J., de Seze, J., deStefano, N., Thouvenot, E., Tintore, M., Tutuncuoglu, M., Uygunoglu, U., Vermersch, P., Weinshenker, B. & Zeydan, B., Aug 1 2020, In: Annals of neurology. 88, 2, p. 407-417 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Magnetic Resonance Imaging 100%
  • Gadolinium 81%
  • Spinal Cord 61%
  • Oligoclonal Bands 53%
  • Proportional Hazards Models 33%
  10 Scopus citations

• Reproductive history and progressive multiple sclerosis risk in women

  Zeydan, B., Atkinson, E. J., Weis, D. M., Smith, C. Y., Gazzuola Rocca, L., Rocca, W. A., Keegan, B. M., Weinshenker, B. G., Kantarci, K. & Kantarci, O. H., 2020, In: Brain Communications. 2, 2, fcaa185.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Reproductive History 100%
  • Multiple Sclerosis 71%
  • Menopause 41%
  • Pregnancy 21%
  • Premature Menopause 21%
• 2019

  Advanced imaging findings in progressive solitary sclerosis: a single lesion or a global disease?

  Lee, L. E., Chan, J. K., Nevill, E., Soares, A., Vavasour, I. M., Macmillan, E. L., Garren, H., Clayton, D., Keegan, B. M., Tam, R., Traboulsee, A. L., Kolind, S. H. & Carruthers, R. L., 2019, In: Multiple Sclerosis Journal - Experimental, Translational and Clinical. 5, 1

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Sclerosis 100%
  • White Matter 84%
  • Multiple Sclerosis 61%
  • Myelin Sheath 47%
  • N-acetylaspartate 29%

• Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology

  Sechi, E., Shosha, E., Williams, J. P., Pittock, S. J., Weinshenker, B. G., Keegan, B. M., Zalewski, N. L., Lopez-Chiriboga, A. S., Jitprapaikulsan, J. & Flanagan, E. P., Jul 23 2019, In: Neurology. 93, 4, p. E414-E420

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myelin-Oligodendrocyte Glycoprotein 100%
  • Transverse Myelitis 99%
  • Aquaporin 4 93%
  • Autoantibodies 63%
  • Epidemiology 54%
  8 Scopus citations

• Clinical, Radiologic, and Prognostic Features of Myelitis Associated with Myelin Oligodendrocyte Glycoprotein Autoantibody

  Dubey, D., Pittock, S. J., Krecke, K. N., Morris, P. P., Sechi, E., Zalewski, N. L., Weinshenker, B. G., Shosha, E., Lucchinetti, C. F., Fryer, J. P., Lopez-Chiriboga, A. S., Chen, J. C., Jitprapaikulsan, J., McKeon, A., Gadoth, A., Keegan, B. M., Tillema, J. M., Naddaf, E., Patterson, M. C., Messacar, K., & 2 othersTyler, K. L. & Flanagan, E. P., Mar 2019, In: JAMA neurology. 76, 3, p. 301-309 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myelin-Oligodendrocyte Glycoprotein 100%
  • Myelitis 96%
  • Autoantibodies 63%
  • Immunoglobulin G 52%
  • Aquaporin 4 29%
  91 Scopus citations

• Late-onset Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes Presenting with Auditory Agnosia

  Smith, K., Chiu, S., Hunt, C., Chandregowda, A., Babovic-Vuksanovic, D. & Keegan, B. M., May 1 2019, In: Neurologist. 24, 3, p. 90-92 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Mitochondrial encephalopathy 100%
  • Agnosia 86%
  • Lactic Acidosis 77%
  • Stroke 41%
  • Mitochondrial Diseases 21%
  2 Scopus citations

• Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis

  Suanprasert, N., Taylor, B. V., Klein, C. J., Roforth, M. M., Karam, C., Keegan, B. M. & Dyck, P. J. B., May 2019, In: Multiple Sclerosis and Related Disorders. 30, p. 284-290 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy 100%
  • Polyneuropathies 83%
  • Multiple Sclerosis 62%
  • Autoantibodies 13%
  • Immunoglobulin G 7%
  2 Scopus citations

• Reply to: “Crowell et al. Idiopathic Central Nervous System Inflammatory Disease in the Setting of HLA-B27 Uveitis”

  Tobin, W. O. & Keegan, B. M., 2019, In: Ocular Immunology and Inflammation. 27, 6, p. 918-919 2 p.

  Research output: Contribution to journal › Letter › peer-review

• Spinal cord infarction in a patient with multiple sclerosis

  Abarbanel, D. N., Zalewski, N. L. & Keegan, B. M., Nov 2019, In: Multiple Sclerosis and Related Disorders. 36, 101435.

  Research output: Contribution to journal › Article › peer-review

  • Myelitis 100%
  • Multiple Sclerosis 95%
  • Infarction 90%
  • Spinal Cord 88%
  • Relapsing-Remitting Multiple Sclerosis 44%

• Unilateral motor progression in MS: Association with a critical corticospinal tract lesion

  Sechi, E., Keegan, B. M., Kaufmann, T. J., Kantarci, O. H., Weinshenker, B. G. & Flanagan, E. P., Aug 13 2019, In: Neurology. 93, 7, p. E628-E634

  Research output: Contribution to journal › Article › peer-review

  • Pyramidal Tracts 100%
  • Multiple Sclerosis 71%
  • Chronic Progressive Multiple Sclerosis 37%
  • Spinal Cord 22%
  • Cerebral Peduncle 20%
  8 Scopus citations
• 2018

  Applying the 2017 McDonald diagnostic criteria for multiple sclerosis

  Sechi, E., Keegan, B. M. & Flanagan, E. P., Jun 2018, In: The Lancet Neurology. 17, 6, p. 498-499 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis

  Jitprapaikulsan, J., Chen, J. J., Flanagan, E. P., Tobin, W. O., Fryer, J. P., Weinshenker, B. G., McKeon, A., Lennon, V. A., Leavitt, J. A., Tillema, J. M., Lucchinetti, C., Keegan, B. M., Kantarci, O., Khanna, C., Jenkins, S. M., Spears, G. M., Sagan, J. & Pittock, S. J., Oct 2018, In: Ophthalmology. 125, 10, p. 1628-1637 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myelin-Oligodendrocyte Glycoprotein 100%
  • Aquaporin 4 93%
  • Autoantibodies 63%
  • Immunoglobulin G 26%
  • Multiple Sclerosis 13%
  45 Scopus citations

• Association of MOG-IgG Serostatus with Relapse after Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders

  López-Chiriboga, A. S., Majed, M., Fryer, J., Dubey, D., McKeon, A., Flanagan, E. P., Jitprapaikulsan, J., Kothapalli, N., Tillema, J. M., Chen, J., Weinshenker, B., Wingerchuk, D., Sagen, J., Gadoth, A., Lennon, V. A., Keegan, B. M., Lucchinetti, C. & Pittock, S. J., Nov 2018, In: JAMA neurology. 75, 11, p. 1355-1363 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Acute Disseminated Encephalomyelitis 100%
  • Immunoglobulin G 51%
  • Recurrence 39%
  • Child 10%
  • Immunotherapy 9%
  97 Scopus citations

• Cervical spinal cord atrophy: An earlymarker of progressiveMSonset

  Zeydan, B., Gu, X., Atkinson, E. J., Keegan, B. M., Weinshenker, B. G., Tillema, J. M., Pelletier, D., Azevedo, C. J., Lebrun-Frenay, C., Siva, A., Okuda, D. T., Kantarci, K. & Kantarci, O. H., Mar 1 2018, In: Neurology: Neuroimmunology and NeuroInflammation. 5, 2, e435.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cervical Cord 100%
  • Atrophy 74%
  • Spine 24%
  • Health Care Outcome Assessment 7%
  35 Scopus citations

• Clinical Reasoning: A 30-year-old man with headache and sleep disturbance

  English, S. W., Keegan, B. M., Flanagan, E. P., Tobin, W. O. & Zalewski, N. L., 2018, In: Neurology. 90, 17, p. E1535-E1540

  Research output: Contribution to journal › Article › peer-review

  Open Access
  2 Scopus citations

• Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses

  Zalewski, N. L., Flanagan, E. P. & Keegan, B. M., Jan 9 2018, In: Neurology. 90, 2, p. e96-e102

  Research output: Contribution to journal › Article › peer-review

  • Transverse Myelitis 100%
  • Spinal Cord Diseases 79%
  • Neurosarcoidosis 12%
  • Myelin-Oligodendrocyte Glycoprotein 11%
  • Neuromyelitis Optica 10%
  40 Scopus citations

• Myelin Oligodendrocyte Glycoprotein Antibody–Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome

  Chen, J. J., Flanagan, E. P., Jitprapaikulsan, J., López-Chiriboga, A. S., Fryer, J. P., Leavitt, J. A., Weinshenker, B. G., McKeon, A., Tillema, J. M., Lennon, V. A., Tobin, W. O., Keegan, B. M., Lucchinetti, C. F., Kantarci, O. H., McClelland, C. M., Lee, M. S., Bennett, J. L., Pelak, V. S., Chen, Y., VanStavern, G., & 7 othersAdesina, O. O. O., Eggenberger, E. R., Acierno, M. D., Wingerchuk, D. M., Brazis, P. W., Sagen, J. & Pittock, S. J., Nov 2018, In: American journal of ophthalmology. 195, p. 8-15 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myelin-Oligodendrocyte Glycoprotein 100%
  • Immunoglobulin G 45%
  • Neurologic Manifestations 17%
  • Visual Acuity 14%
  • Ocular Vision 14%
  117 Scopus citations

• Population-based study of "no evident disease activity" in MS

  Parks, N. E., Pittock, S. J., Mandrekar, J., Kantarci, O. H., Lucchinetti, C. F., Weinshenker, B. G., Mark Keegan, B., Oliver Tobin, W., Tillema, J. M., Toledano, M. & Flanagan, E. P., Nov 1 2018, In: Neurology: Neuroimmunology and NeuroInflammation. 5, 6, e495.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Population 100%
  • Medical Record Linkage 40%
  • Mitoxantrone 30%
  • Injections 13%
  • Recurrence 13%
  2 Scopus citations

• Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease

  Keegan, B. M., Kaufmann, T. J., Weinshenker, B. G., Kantarci, O. H., Schmalstieg, W. F., Paz Soldan, M. M. & Flanagan, E. P., Oct 1 2018, In: Multiple Sclerosis Journal. 24, 11, p. 1445-1452 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Central Nervous System Diseases 100%
  • Demyelinating Diseases 96%
  • Magnetic Resonance Imaging 60%
  • Central Nervous System 40%
  • Paresis 38%
  9 Scopus citations

• Reply: A case of CLIPPERS challenging the new diagnostic criteria

  Tobin, W. O., Guo, Y., Krecke, K. N. & Mark Keegan, B., Feb 1 2018, In: Brain. 141, 2, p. e13

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Scopus citations

• Reply: Two cases of CLIPPERS with increased number of perivascular CD20-positive B lymphocytes

  Oliver Tobin, W., Guo, Y. & Mark Keegan, B., Oct 1 2018, In: Brain. 141, 10

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Scopus citations

• Reply: CLIPPERS, a possible symptomatic lymphohistiocytic immune reaction

  Tobin, W. O., Guo, Y. & Keegan, B. M., Jan 1 2018, In: Brain : a journal of neurology. 141, 1, p. e6

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Trident sign trumps Aquaporin-4-IgG ELISA in diagnostic value in a case of longitudinally extensive transverse myelitis

  Jolliffe, E. A., Keegan, B. M. & Flanagan, E. P., Jul 2018, In: Multiple Sclerosis and Related Disorders. 23, p. 7-8 2 p.

  Research output: Contribution to journal › Article › peer-review

  • Transverse Myelitis 100%
  • Aquaporin 4 94%
  • Sarcoidosis 75%
  • Spinal Cord 57%
  • Immunoglobulin G 52%
  6 Scopus citations
• 2017

  Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)

  Tobin, W. O., Guo, Y., Krecke, K. N., Parisi, J. E., Lucchinetti, C. F., Pittock, S. J., Mandrekar, J., Dubey, D., Debruyne, J. & Keegan, B. M., Sep 1 2017, In: Brain. 140, 9, p. 2415-2425 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Steroids 100%
  • Inflammation 78%
  • Neuropathology 20%
  • Adrenal Cortex Hormones 14%
  • Gadolinium 13%
  72 Scopus citations

• Diagnostic value of brain calcifications in adult-onset leukoencephalopathy with axonal spheroids and pigmented glia

  Konno, T., Broderick, D. F., Mezaki, N., Isami, A., Kaneda, D., Tashiro, Y., Tokutake, T., Keegan, B. M., Woodruff, B. K., Miura, T., Nozaki, H., Nishizawa, M., Onodera, O., Wszolek, Z. K. & Ikeuchi, T., Jan 2017, In: American Journal of Neuroradiology. 38, 1, p. 77-83 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Leukoencephalopathies 100%
  • White Matter 68%
  • Neuroglia 66%
  • Colony-Stimulating Factor Receptors 57%
  • Macrophage Colony-Stimulating Factor 45%
  31 Scopus citations
• 2016

  Discriminating long myelitis of neuromyelitis optica from sarcoidosis

  Flanagan, E. P., Kaufmann, T. J., Krecke, K. N., Aksamit, A. J., Pittock, S. J., Keegan, B. M., Giannini, C. & Weinshenker, B. G., Mar 1 2016, In: Annals of neurology. 79, 3, p. 437-447 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Myelitis 100%
  • Neuromyelitis Optica 97%
  • Sarcoidosis 78%
  • Spinal Cord 58%
  • Transverse Myelitis 11%
  78 Scopus citations

• Primary Progressive Multiple Sclerosis Evolving from Radiologically Isolated Syndrome

  Kantarci, O. H., Lebrun, C., Siva, A., Keegan, M. B., Azevedo, C. J., Inglese, M., Tintoré, M., Newton, B. D., Durand-Dubief, F., Amato, M. P., De Stefano, N., Sormani, M. P., Pelletier, D. & Okuda, D. T., Feb 1 2016, In: Annals of neurology. 79, 2, p. 288-294 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Chronic Progressive Multiple Sclerosis 100%
  • Spinal Cord 9%
  • Population 6%
  • Age of Onset 5%
  • Demography 3%
  85 Scopus citations

• Progressive solitary sclerosis: Gradual motor impairment from a singleCNSdemyelinating lesion

  Keegan, B. M., Kaufmann, T. J., Weinshenker, B. G., Kantarci, O. H., Schmalstieg, W. F., Paz Soldan, M. M. & Flanagan, E. P., Oct 18 2016, In: Neurology. 87, 16, p. 1713-1719 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Sclerosis 100%
  • Multiple Sclerosis 81%
  • Spinal Cord 56%
  • Paresis 49%
  • Demyelinating Diseases 48%
  42 Scopus citations

• Serial cerebrospinal fluid examinations to diagnose hematological malignancy causing neurological disease

  Scharf, E. L., Hanson, C. A., Howard, M. T. & Keegan, B. M., Aug 1 2016, In: Journal of neuro-oncology. 129, 1, p. 77-83 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Hematologic Neoplasms 100%
  • Cerebrospinal Fluid 85%
  • Cerebrospinal Fluid Shunts 8%
  • Pseudotumor Cerebri 7%
  • Cerebrospinal Fluid Leak 6%
  2 Scopus citations

• The contemporary spectrum of multiple sclerosis misdiagnosis

  Solomon, A. J., Bourdette, D. N., Cross, A. H., Applebee, A., Skidd, P. M., Howard, D. B., Spain, R. I., Cameron, M. H., Kim, E., Mass, M. K., Yadav, V., Whitham, R. H., Longbrake, E. E., Naismith, R. T., Wu, G. F., Parks, B. J., Wingerchuk, D. M., Rabin, B. L., Toledano, M., Tobin, W. O., & 4 othersKantarci, O. H., Carter, J. L., Keegan, B. M. & Weinshenker, B. G., Sep 27 2016, In: Neurology. 87, 13, p. 1393-1399 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Diagnostic Errors 100%
  • Multiple Sclerosis 90%
  • Neurologic Manifestations 23%
  • Conversion Disorder 16%
  • Neuromyelitis Optica 15%
  122 Scopus citations
• 2015

  Conjunctival biopsy to diagnose neurosarcoidosis in patients with inflammatory nervous system disease of unknown etiology

  Pichler, M. R., Flanagan, E. P., Aksamit, A. J., Leavitt, J. A., Salomaõ, D. R. & Keegan, B. M., Jun 10 2015, In: Neurology: Clinical Practice. 5, 3, p. 216-223 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Neurosarcoidosis 100%
  • Nervous System Diseases 59%
  • Biopsy 38%
  • Nerve Tissue 10%
  • Sarcoidosis 9%
  3 Scopus citations

• Diagnostic yield and safety of cerebellar and brainstem parenchymal biopsy

  Tobin, W. O., Meyer, F. B. & Keegan, B. M., Dec 1 2015, In: World neurosurgery. 84, 6, p. 1973-1976 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Brain Stem 100%
  • Biopsy 67%
  • Safety 64%
  • Hypesthesia 36%
  • Neurologic Manifestations 32%
  8 Scopus citations

• Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis

  Novotna, M., Paz Soldán, M. M., Zeid, N. A., Kale, N., Tutuncu, M., Crusan, D. J., Atkinson, E. J., Siva, A., Keegan, B. M., Pirko, I., Pittock, S. J., Lucchinetti, C. F., Noseworthy, J. H., Weinshenker, B. G., Rodriguez, M. & Kantarci, O. H., Aug 25 2015, In: Neurology. 85, 8, p. 722-729 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Recurrence 64%
  • Chronic Progressive Multiple Sclerosis 24%
  • Relapsing-Remitting Multiple Sclerosis 10%
  • Population 10%
  50 Scopus citations

• Relapses and disability accumulation in progressive multiple sclerosis

  Soldán, M. M. P., Novotna, M., Zeid, N. A., Kale, N., Tutuncu, M., Crusan, D. J., Atkinson, E. J., Siva, A., Keegan, B. M., Pirko, I., Pittock, S. J., Lucchinetti, C. F., Weinshenker, B. G., Rodriguez, M. & Kantarci, O. H., 2015, In: Neurology. 84, 1, p. 81-88 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Chronic Progressive Multiple Sclerosis 78%
  • Recurrence 64%
  • Immunomodulation 48%
  • Confidence Intervals 42%
  60 Scopus citations
• 2014

  A CNS multifocal disease: Important diagnostic considerations regarding multiple sclerosis

  Tillema, J. M., Renaud, D. & Keegan, B. M., May 2014, In: Multiple Sclerosis and Related Disorders. 3, 3, p. 402-407 6 p.

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• Dementia in MS complicated by coexistent Alzheimer disease: Diagnosis premortem and postmortem

  Flanagan, E. P., Knopman, D. S. & Keegan, B. M., Jun 2014, In: Neurology: Clinical Practice. 4, 3, p. 226-230 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Dementia 94%
  • Alzheimer Disease 87%
  • Biomarkers 55%
  • Amyloid 53%
  8 Scopus citations

• In reply - Sensitivity of [¹⁸F]-fluorodeoxyglucosee positron emission tomography in patients with active myelopathy

  Keegan, B. M. & Flanagan, E. P., Jun 2014, In: Mayo Clinic proceedings. 89, 6, p. 859 1 p.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• Radiologically isolated syndrome: 5-year risk for an initial clinical event

  Okuda, D. T., Siva, A., Kantarci, O., Inglese, M., Katz, I., Tutuncu, M., Keegan, B. M., Donlon, S., Hua, L. H., Vidal-Jordana, A., Montalban, X., Rovira, A., Tintoré, M., Amato, M. P., Brochet, B., De Seze, J., Brassat, D., Vermersch, P., De Stefano, N., Sormani, M. P., & 2 othersPelletier, D. & Lebrun, C., Mar 5 2014, In: PloS one. 9, 3, e90509.

  Research output: Contribution to journal › Article › peer-review

  • Spinal Cord 100%
  • Demyelinating Diseases 64%
  • Brain 59%
  • Proportional Hazards Models 54%
  • Multivariate Analysis 43%
  175 Scopus citations